Medicine and Dentistry
Hu Antibody
100%
Head and Neck Cancer
100%
Paraneoplastic Cerebellar Degeneration
100%
Neurologic Disease
100%
Spindle Cell Carcinoma
66%
Paraneoplastic Syndrome
66%
Nasal Cavity
33%
Nervous System Disorder
33%
Differential Diagnosis
33%
Paranasal Sinus
33%
Chemoradiotherapy
33%
Tumor Recurrence
33%
Cancer
33%
Small Cell Lung Cancer
33%
Neck
33%
Neoplasm
33%
Ataxia
33%
Recurrent Disease
33%
Biochemistry, Genetics and Molecular Biology
Overall Survival
100%
Progression Free Survival
100%
ERCC1
50%
XRCC1
50%
SLCO1B3
50%
ERCC2
50%
Genetic Polymorphism
50%
Fluorouracil
50%
Cisplatin
50%
Genotyping
50%
Genetic Marker
50%
Pharmacology, Toxicology and Pharmaceutical Science
Head and Neck Cancer
100%
Chemotherapy
100%
Docetaxel
42%
Progression Free Survival
28%
Overall Survival
28%
Infection
14%
Combination Therapy
14%
Leukopenia
14%
Infectious Complication
14%
SLCO1B3
14%
Cisplatin
14%
Fluorouracil
14%
